Retrospective study comparing the safety and treatment outcome of EGb 761 to donepezil in patient with Alzheimer's dementia.

Trial Profile

Retrospective study comparing the safety and treatment outcome of EGb 761 to donepezil in patient with Alzheimer's dementia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2018

At a glance

  • Drugs Donepezil (Primary) ; EGb 761 (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jan 2018 New trial record
    • 10 Jan 2018 Results published in the International Journal of Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top